GSK Infanrix hexa & sudden death: a review of the safety update reports submitted to EMA

In their peer reviewed commentary in the Indian Journal of Medical Ethics, Dr. Jacob Puliyel, Head of Pediatrics, St. Stephen’s Hospital and C Sathyamala, Public Health Physician and Epidemiologist, examine sudden infant deaths following vaccination with GlaxoSmithKline’s hexavalent (6 in 1) “Infanrix hexa” . . . Continue reading →